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In The Creative Destruction of Medicine, geneticist and cardiologist Eric Topol introduces a
radical new approach to medicine. By bringing the era of big data and personal technology to
the clinic, laboratory, and hospital, doctors can see a full, continuously updated picture of each
patient and treat each individually. Edward Larkin believes that although Topol’s vision may
be somewhat premature, the book is a must-read for anyone interested in the relationship
between technology of medicine. 
The Creative Destruction of Medicine: How the Digital Revolution Will Create Better
Health Care. Eric Topol. Basic Books. April 2012.
Every once in a great while, amidst the doomsday predictions about the
percentage of  GDP that will be eaten up by health care in 2050, the
drumbeat of  reports about the astonishing amount of  money spent on
“waste” and “unnecessary care”, and the horror stories about
inequalit ies, waiting lists and the privations of  insurance companies,
someone dares to strike an optimistic note about the f uture of  health
care. Eric Topol, a prominent cardiologist at Scripps Research Institute in
San Diego, is one of  these rare optimists, and his recent book, The
Creative Destruction of Medicine: How the Digital Revolution Will Create
Better Health Care, is an exhilarating account of  the coming intersection
of  technology and medicine.
Topol’s basic thesis is that we are on the cusp of  a “super-convergence”
in medicine, made possible by cheap genetic sequencing, ubiquitous
sensors that track physiological metrics, and constant wireless internet
connection. In Topol’s vision of  medicine in 15 years, each of  us will have
on or in us tiny sensors that track blood pressure, oxygen saturation, blood glucose, heart and respiratory
rates, and other metrics. These will in turn be continuously uploaded to the Cloud, f iltered through
algorithms made to detect trouble, and if  such trouble manif ests itself , alert physicians. If  this seems like a
f ar cry f rom the medicine we all know and (I would say love, but somehow that doesn’t seem appropriate),
that’s because it is. Topol recognizes the radical nature of  what he ref ers to as the “digit ization of  human
beings,” predicting that we are about to witness “the biggest shakeup in medicine’s history.”
The digital tools that will usher in these changes – sensors to detect calories burned, steps walked, sleep
cycles, blood pressure, and blood glucose – are either already available or will soon be soon. AliveCor sells
an iPhone case that doubles as a mobile electrocardiogram, and researchers at the University of  Illinois
recently developed a f lexible electronic skin tattoo that can pick up physiological metrics. These are all
serious innovations, but to label any as ready to meaningf ully improve health would be sensationalist.
However, any preliminary study of  history of  computation over the past f if ty years teaches us that it ’s
highly unwise to ever bet against it. Where data and computation can encroach, they do.
The more salient question is whether the human body can be “digit ized,” as Topol puts it, in the f irst place.
Thirteen years ago, on the eve of  the completion of  the human genome project, people spoke breathlessly
of  an age in which disease risk was known and thus quantif iable and preventable. All one had to do was
read the genetic code, and an individual’s f uture medical history would be laid out like a deciphered
hieroglyphic. This hope has diminished considerably over the past decade, as researchers learned swif t ly
that there’s no such thing as the “f at gene” or the “height gene,” and that even seemingly straightf orward
diseases have mind-numbingly cacophonous genetic prof iles. The environment is much more important
than we imagined, and f iguring out how to understand the ef f ect it has on genes is just beginning to be
understood. There’s certainly a chance f or breakthroughs in the near f uture, but the genome looks a lot
less like the Rosetta Stone than it once did. To his credit, Topol is is quick to point out that the gains of
genetics haven’t materialized f ully, although f or some reason, his general optimism remains undiminished.
Despite the impressive amount of  technical detail contained in the book, one need not have a sophisticated
understanding of  either biology or medicine to grasp the magnitude of  some of  Topol’s suggestions. For
example, he discusses the potential f or nanosensors in the bloodstream to detect a heart attack bef ore it
happens, based on a high concentration of  cells that have been sloughed f rom artery walls, alerting the
patient of  an impending event via smartphone. Eventually, Topol says, the sensors might even be able to
squirt out drugs on demand, completely closing the loop. He also predicts that cancer will be much more
ef f ectively dealt with, as the “tumor genome” is repeatedly sequenced to identif y important mutations, and
tailored chemotherapy delivered. If  and when these innovations come to pass, they will be game changers.
Topol is convinced that consumers, not physicians, will lead the charge towards digit ized medicine. For the
most part, he is right. Organized medicine’s clumsy attempted blockade of  personal genetics companies
indicates a prof ession that clearly isn’t ready to lead. As medicine becomes more standardized, rule-based,
and predictive, the demand f or highly paid doctors will diminish. Recent walk- in clinics that are staf f ed by
nurses and run at a f raction of  the cost are proof  of  this. But this legit imate conviction morphs into a latent
hostility towards organized medicine that is, at best, distracting. Topol calls medicine “sclerotic, even
ossif ied,” an illegit imate “priesthood,” a “cocoon,” and accuses it of  being the prof ession most resistant to
change on the planet. Granted, Topol presumably isn’t interested in winning over doctors, but his consistent
vitriol sometimes takes away f rom the point at hand.
The major question f or Topol’s argument is whether people really care about their health. Not care in the
banal sense – everyone is notionally interested in remaining alive and healthy. Care in the sacrif icial sense –
are people actually willing to put ef f ort into maintaining health, enough to buy the sensors he talks about or
make the lif estyle changes necessary af ter receiving their genetic inf ormation? The answer here is certainly
less than a resounding yes. Most of  us eat f ar more poorly even though we know exactly what a healthy
diet would look like. Many of  us work out f ar less of ten than we should, even though we have enough time
to do so. Maintaining health simply isn’t fun, especially because the ef f ect is so dif f use and vague. The
marginal calorie I eat right now tastes great right now – the benef it accrues immediately. Presumably, it
negatively af f ects my health. But when? In 6 months? A year? 20 years? The marginal cost is almost
completely invisible.
Indeed, a study by Topol himself  and his colleagues themselves f ound that, while individuals actually do
prove to be resilient in terms of  reacting to bad news f rom genetic tests, they don’t change their behaviour
much at all even to prevent health problems. Thus, access to genetic inf ormation alone probably won’t
change many people’s behaviour. This certainly mirrors my own experience. I paid f or a genetic test f rom the
company 23andMe last summer. While the results were inf ormative, even high risks f or certain diseases
didn’t motivate me to do any research on what I could do to avoid them, much less make the dif f icult
lif estyle changes necessary. And this is coming f rom a medical student who is interested in this stuf f .
In 2015 and perhaps even 2020, health care will probably still resemble what we experience today rather
than Topol’s digital utopia. Perhaps some of  Topol’s suggestions are premature. But this is precisely the
issue – prematurity. These things will happen, at some point. It ’s just a matter of  when. Which is a crucial
question, because if  anything is going to save the day, it is going to be technology. Until technology f inally
steps in to save us f rom ourselves, the sheer momentum of  normality and a daily routine prevents most of
us f rom changing our behaviour much. Basically anything that takes any sustained, unpleasant ef f ort with
uncertain rewards will not be done. But I would put my money on the f act that come 2040, Topol’s vision will
prove much more durable than any of  the other shrill predictions that are out there.
——————————————————————————————-
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